Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.570
+0.050 (1.98%)
At close: May 29, 2026, 4:00 PM EDT
2.579
+0.009 (0.35%)
After-hours: May 29, 2026, 6:58 PM EDT
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $1.06M in the quarter ending March 31, 2026, with 45.54% growth. This brings the company's revenue in the last twelve months to $3.91M, up 33.26% year-over-year. In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%.
Revenue (ttm)
$3.91M
Revenue Growth
+33.26%
P/S Ratio
1.57
Revenue / Employee
$71,150
Employees
55
Market Cap
6.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.72K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.29% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 19.57M |
| Beyond Air | 6.92M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| ENvue Medical | 2.18M |
| Sintx Technologies | 1.03M |
| iTonic Holdings | 523.03K |
| HeartSciences | 8.67K |
INBS News
- 18 days ago - Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions announces launch of validation study for IFDSS - TheFly
- 5 weeks ago - Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions announces completion of penetrating testing - TheFly
- 6 weeks ago - Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified - GlobeNewsWire
- 2 months ago - Intelligent Bio completes initial drug screening system clinical cut-off study - TheFly
- 2 months ago - Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant - GlobeNewsWire